Low Frequency Subthalamic Nucleus Deep Brain Stimulation to Improve Verbal Fluency
Evaluation of Neurocognitive Changes in Parkinson's Disease Patients Following Acute Low Frequency Deep Brain Stimulation
1 other identifier
interventional
12
1 country
1
Brief Summary
Rationale: Parkinson's disease patients with deep brain stimulation electrodes represent a unique opportunity to study the influence of basal ganglia on neurocognitive function. Intervention: Patients' deep brain stimulators will be turned off or on and the frequency will be changed to either theta or gamma. Objectives: To identify differences in higher cognitive functions with stimulation "on" and "off" and theta versus gamma frequency stimulation. Study population: 12 patients who had previously undergone bilateral STN deep brain stimulation implantation. Study methodology: Patients will undergo four sessions of neuropsychological testing (RNGT, verbal fluency, D-KEFS CWIT) at baseline, no stimulation, theta stimulation and gamma stimulation, in random order over one day. Study outcomes: Test results of RNGT, verbal fluency, D-KEFS CWIT. Follow-up: none Statistics: Test results will be analyzed using within-subjects statistical tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started Jan 2020
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2020
CompletedFirst Submitted
Initial submission to the registry
May 7, 2020
CompletedFirst Posted
Study publicly available on registry
May 12, 2020
CompletedResults Posted
Study results publicly available
July 15, 2021
CompletedJuly 15, 2021
June 1, 2021
1 month
May 7, 2020
May 6, 2021
June 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Delis-Kaplan Executive Function System Verbal Fluency
Number of words per category in one minute
5-15 minutes following stimulation frequency setting change.
Delis-Kaplan Executive Function System Color Word Interference Task
Time to completion of a color-word interference task
5-15 minutes following stimulation frequency setting change.
Random Number Generation
Listing of 100 numbers at 1 Hz in a random order. Evan's RNG: a measure of disproportion with which one number follows another in a sequence. Scores range from 0 (equal proportion of sequence pairs) to 1 (maximum disproportion of sequence pairs). A higher score indicates a lower randomness and poorer exective function. Count score 1: a measure of propensity to count in steps of 1. The length of each sequence with steps of 1 is squared. The total of these is summed. Scores range from 0 (no sequences with steps of 1) to 100000 (all sequences with steps of 1). A higher score indicates lower randomness and poorer exective function. Count score 2: a measure of propensity to count in steps of 2. The length of each sequence with steps of 2 is squared. The total of these is summed. Scores range from 0 (no sequences with steps of 2) to 100000 (all sequences with steps of 2). A higher score indicates lower randomness and poorer exective function. Evan's RNG, count score 1 and cou
5-15 minutes following stimulation frequency setting change.
Study Arms (3)
STN DBS off
SHAM COMPARATORSTN DBS 10Hz
EXPERIMENTALSTN DBS 130Hz
ACTIVE COMPARATORInterventions
Stimulation of existing DBS device at 100Hz, with other parameters at baseline
Stimulation of existing DBS device at 130Hz, with other parameters at baseline
Eligibility Criteria
You may qualify if:
- Male or female patients who had previously undergone bilateral STN deep brain stimulation implantation
- Age \>18 years old
- Stable medication regimen for at least 3 months.
- Patient informed and able to give written consent
- Able to comply with all testing, follow-ups and study appointments and protocols
You may not qualify if:
- History of epilepsy or seizure
- History of major substance abuse
- Patients with baseline settings at less than 1.5 V will be excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Keck hospital of the University of Southern California
Los Angeles, California, 90033, United States
Related Publications (3)
Evans FJ. Monitoring attention deployment by random number generation: An index to measure subjective randomness. Bull Psychon Soc 1978;12:35-8.
BACKGROUNDSpatt J, Goldenberg G. Components of random generation by normal subjects and patients with dysexecutive syndrome. Brain Cogn. 1993 Nov;23(2):231-42. doi: 10.1006/brcg.1993.1057.
PMID: 8292327BACKGROUNDTowse JN, Neil D. Analyzing human random generation behavior: A review of methods used and a computer program for describing performance. Behav Res Methods Instrum Comput 1998;30:583-91.
BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Our study did not control for motor state during testing. Our sample population was not fully representative of the worldwide population of patients with PD. Our study was not designed nor powered to investigate inter-subject differences such as age, time from DBS implantation, education, first language, or motor function. Unknown is the adequacy of a 5-min period of stimulation prior to each round of neuropsychological testing.
Results Point of Contact
- Title
- Dr Darrin Lee
- Organization
- Keck School of Medicine of University of Southern California
Study Officials
- PRINCIPAL INVESTIGATOR
Darrin J Lee, MD PhD
University of Southern California
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Neurosurgery
Study Record Dates
First Submitted
May 7, 2020
First Posted
May 12, 2020
Study Start
January 31, 2020
Primary Completion
March 3, 2020
Study Completion
March 3, 2020
Last Updated
July 15, 2021
Results First Posted
July 15, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share